Trademark: 77551231
Status Date
Friday, December 7, 2018
Registration Number
4135778
Registration Date
Tuesday, May 1, 2012
Filing Date
Wednesday, August 20, 2008
Published for Opposition
Tuesday, November 16, 2010
Cancellation Date
Friday, December 7, 2018
16 printed reports and printed visuals, namely, information graphics providing statewide, market area, payer, hospital, and physician measurements on outcomes, quality, mortality, infections, complications, utilization, and price for use by third party payers, hospitals, physicians, healthcare organizations, insurance companies, HMOs, employers, legal counsel, the media, government entities and consumers
35 consulting services related to medical cost management; management services of a business nature for clinical trials in the field of investigational drugs; data compilation and analysis in the field of healthcare management, namely, conducting pharmacoeconomics, health economics and statistical research for business purposes; computerized database management and data processing services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; computerized database management and data processing services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; business consulting services in the fields of healthcare, pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; supply chain management, namely, tracking and management of clinical trial supplies and research materials used in such; providing statistical information and analysis via computer for use with clinical trial data for business purposes; business consultation services for the healthcare industry; business consulting in the field of clinical and health economic research services for healthcare companies; preparing statistical business reports resulting from clinical trials and laboratory data analysis; consultation in the field of patient recruitment; data preparation for business purposes, namely, preparation of medical and scientific data for use by insurance companies and third party medical reimbursement organizations
42 medical and scientific research, data collection and analysis in the nature of clinical research and conducting clinical trials in the fields of healthcare, medical care and pharmaceuticals; scientific research in the field of general health and medical and scientific research, namely, conducting clinical trials by providing clinical indicators calculated using medical claims data that are used to measure quality of medical care; compilation and analysis in the field of scientific and medical research, namely, conducting pharmacoeconomics, health economics, medical laboratory data analysis, and statistical medical research; pharmaceutical development services in the fields of molecular medicine; healthcare, namely, scientific research consulting for improved clinical trial design; medical research that analyzes data to identify patterns across patient groups or disease progression; pharmaceutical development, namely, design, research and development of drugs, pharmaceuticals and medicines for others; clinical development services for others, namely, research and consultation in the fields of pharmaceutical drug development and clinical trial design; medical laboratory data analysis, clinical diagnosis research and diagnostic testing research; preparation of reports and research concerning development of medicines, pharmaceuticals, genetics, biology, biotechnology and pharmaceutical drugs; consulting services in the fields of pharmaceuticals research, and biotechnology fields; providing an on-line database in the field of medical, pharmaceutical, and biotechnical research and analysis; management services of a scientific and technical nature for clinical trials in the field of investigational drugs, namely, conducting clinical protocols and trials for others; consulting services regarding scientific aspects of clinical trials of investigational drugs, namely, advising others on conducting clinical protocols and trials; technical writing for others of clinical trial reports; research and consultation in the clinical medical field, namely, research and analysis provided to healthcare providers, suppliers of medical devices and pharmaceutical products, and suppliers of medical software and medical information management services; medical quality evaluation services, namely, providing data collection, analysis, and reporting services for patient data, clinical information, treatment options and treatment success for the medical industry; providing an on-line computer database in the field of healthcare, namely, health and productivity research and analysis; assessment surveys for health and medical purposes, namely, in research concerning medicines, pharmaceuticals, genetics, biology, biotechnology and drugs; quality evaluation services, namely, surveying patients to assess quality of life, burden of disease and overall satisfaction with access to medical care to determine service quality for the medical industry
44 consultation in the field of drug use testing services; consultation in the field of healthcare; providing pharmaceutical advice; providing an interactive on-line computer database in the field of medical diagnostics
45 consulting services in the field of research and analysis of drug prescription and associated data, namely, regulatory compliance consulting as it applies to prescription drug sampling
The color(s) blue, green, and teal is/are claimed as a feature of the mark.
The mark consists of three stylized curved triangles surrounding a central point, each with a concave inner surface; one of the triangles is blue, one green, and one teal.
Dec 7, 2018
Cancelled Sec. 8 (6-Yr)
Jul 9, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 9, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 27, 2018
Assignment Of Ownership Not Updated Automatically
May 1, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
May 2, 2012
Automatic Update Of Assignment Of Ownership
May 1, 2012
Registered-Principal Register
Apr 24, 2012
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 24, 2012
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 30, 2012
Notice Of Acceptance Of Statement Of Use Mailed
Mar 29, 2012
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 28, 2012
Law Office Registration Review Completed
Mar 27, 2012
Allowed Principal Register - Sou Accepted
Mar 1, 2012
Statement Of Use Processing Complete
Feb 1, 2012
Use Amendment Filed
Mar 1, 2012
Case Assigned To Intent To Use Paralegal
Feb 1, 2012
Teas Statement Of Use Received
Jan 31, 2012
Noa E-Mailed - Sou Required From Applicant
Dec 22, 2011
Ttab Release Case To Trademarks
Dec 22, 2011
Opposition Terminated No. 999999
Dec 22, 2011
Opposition Dismissed No. 999999
Mar 17, 2011
Teas Withdrawal Of Attorney Received-Firm Retains
Mar 16, 2011
Opposition Instituted No. 999999
Dec 6, 2010
Exparte Appeal Terminated
Dec 1, 2010
Extension Of Time To Oppose Received
Nov 16, 2010
Official Gazette Publication Confirmation E-Mailed
Nov 16, 2010
Published For Opposition
Oct 13, 2010
Law Office Publication Review Completed
Oct 13, 2010
Approved For Pub - Principal Register
Oct 13, 2010
Examiner's Amendment Entered
Oct 13, 2010
Notification Of Examiners Amendment E-Mailed
Oct 13, 2010
Examiners Amendment E-Mailed
Oct 13, 2010
Examiners Amendment -Written
Sep 22, 2010
Teas/Email Correspondence Entered
Sep 22, 2010
Correspondence Received In Law Office
Sep 20, 2010
Teas Request For Reconsideration Received
Sep 20, 2010
Ex Parte Appeal-Instituted
Sep 20, 2010
Jurisdiction Restored To Examining Attorney
Sep 20, 2010
Exparte Appeal Received At Ttab
Mar 31, 2010
Notification Of Final Refusal Emailed
Mar 31, 2010
Final Refusal E-Mailed
Mar 31, 2010
Final Refusal Written
Mar 8, 2010
Teas/Email Correspondence Entered
Mar 8, 2010
Correspondence Received In Law Office
Mar 8, 2010
Teas Response To Office Action Received
Sep 7, 2009
Notification Of Priority Action E-Mailed
Sep 7, 2009
Priority Action E-Mailed
Sep 7, 2009
Priority Action Written
Aug 4, 2009
Previous Allowance Count Withdrawn
Jul 17, 2009
Withdrawn From Pub - Og Review Query
Jul 9, 2009
Law Office Publication Review Completed
Jul 9, 2009
Assigned To Lie
Jun 30, 2009
Approved For Pub - Principal Register
May 29, 2009
Teas/Email Correspondence Entered
May 29, 2009
Correspondence Received In Law Office
May 29, 2009
Teas Response To Office Action Received
Nov 29, 2008
Notification Of Non-Final Action E-Mailed
Nov 29, 2008
Non-Final Action E-Mailed
Nov 29, 2008
Non-Final Action Written
Nov 20, 2008
Assigned To Examiner
Aug 26, 2008
Notice Of Design Search Code Mailed
Aug 25, 2008
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
